SCHEMBL24185602

SCHEMBL24185602

Clc1ccnn1-c1ccc(Br)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPBWR1 P48145 1/20 0.40
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
LMNA P02545 1/20 0.38
GLA P06280 1/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
POLB P06746 2/20 0.35
MAPT P10636 3/20 0.34
ALDH1A1 P00352 2/20 0.34
ATM Q13315 1/20 0.34
SMPD1 P17405 1/20 0.34
FAAH O00519 1/20 0.33
MGLL Q99685 1/20 0.33
KDM4E B2RXH2 1/20 0.33
CYP2A6 P11509 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27822210 0.79 OXTR (0.48) NPBWR1MEN1KMT2APOLBALDH1A1
SCHEMBL27906302 0.78 POLB (0.57) NPBWR1NPC1RAB9AMEN1KMT2A
SCHEMBL28747951 0.78 NPBWR1 (0.42) NPBWR1NPC1RAB9AMEN1KMT2A
SCHEMBL2555958 0.77 NPBWR1 (0.45) NPBWR1MEN1KMT2APOLBMAPT
SCHEMBL15299343 0.75 NPC1 (0.41) NPBWR1NPC1RAB9AMEN1KMT2A
SCHEMBL4951229 0.75 POLB (0.64) NPBWR1NPC1RAB9AMEN1KMT2A
SCHEMBL15553978 0.75 NPC1 (0.38) NPBWR1NPC1RAB9AMEN1KMT2A
SCHEMBL28179494 0.73 KDM5A (0.50) MEN1KMT2ASMPD1USP8KDM5A
SCHEMBL18865532 0.72 NPBWR1 (0.44) NPBWR1NPC1RAB9AMEN1KMT2A
SCHEMBL24303668 0.71 KDM4E (0.47) NPBWR1NPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230373985-A1 KINASE MODULATORS AND METHODS OF USE THEREOF ORIGENIS GMBH (DE) 2023-11-23 US disclosed
US-20230373985-A1 KINASE MODULATORS AND METHODS OF USE THEREOF ORIGENIS GMBH (DE) 2023-11-23 US disclosed
WO-2022011338-A2 KINASE MODULATORS AND METHODS OF USE THEREOF ORIGENIS GMBH (DE) 2022-01-13 WO disclosed
WO-2022011337-A1 KINASE MODULATORS AND METHODS OF USE THEREOF ORIGENIS GMBH (DE) 2022-01-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230373985-A1 KINASE MODULATORS AND METHODS OF USE THEREOF TYK2, MAPKAPK2, MAP3K20 NPBWR1 3126/4885NPC1 4872/4885RAB9A 3331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.